S

Scott W. Lowe

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-5284-9650

Publishes on Cancer-related Molecular Pathways, Lung Cancer Treatments and Mutations, Immune cells in cancer. 1k papers and 107.7k citations.

PubIndex Score98Top 2%How it's scored

🌟#10 Current Senior Leader in Cancer-related Molecular Pathways

1kPublications

107.7kTotal Citations

#10in Cancer-related Molecular Pathways

First publication: 1988First senior author: 1997

Cancer-related Molecular Pathways Lung Cancer Treatments and Mutations Immune cells in cancer Protein Degradation and Inhibitors Epigenetics and DNA Methylation

Top publicationsby citations

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

Yuchen Chien, Scott W. Lowe|Genes & Development|2011

Cited by 990

Dissecting eIF4E action in tumorigenesis

Hans-Guido Wendel, Scott W. Lowe|Genes & Development|2007

Cited by 476

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

Julien Dilly, Brian M. Wolpin, Andrew J. Aguirre et al.|Cancer Discovery|2024

Cited by 234

Ordered and deterministic cancer genome evolution after p53 loss

Timour Baslan, Scott W. Lowe|Nature|2022

Cited by 232

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma

Chun‐Hao Huang, Scott W. Lowe|Genes & Development|2014

Cited by 201